C94.42
Acute panmyelosis with myelofibrosis, in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute panmyelosis with myelofibrosis in relapse is a rare but serious blood disorder characterized by the rapid proliferation of abnormal blood cells and the development of fibrous tissue within the bone marrow. This condition signifies a recurrence of a previous disorder and requires careful medical assessment. It affects the blood cell production, leading to various health complications, and is classified under ICD-10 code C94.42. Recognizing the signs and understanding its nature is essential for timely medical intervention.
Causes & Symptoms
Clinical Causes: Previous history of myeloproliferative disorders Genetic mutations affecting blood cell production Exposure to certain chemotherapy agents or radiation Chronic bone marrow stress from other hematological conditions Underlying immune system abnormalities
Key Symptoms: Persistent fatigue and weakness Unexplained bleeding or easy bruising Frequent infections due to low white blood cell counts Shortness of breath and dizziness Swelling or pain in the bones or joints Unintentional weight loss Fever and night sweats
Diagnostic & Treatment
Diagnosis Path: Diagnosing acute panmyelosis with myelofibrosis in relapse involves comprehensive laboratory and clinical evaluations. Tests typically include:
Treatment Protocols: Managing this condition often involves complex therapeutic strategies aimed at controlling disease progression and alleviating symptoms. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is C94.42 a billable ICD-10 code?
Yes, C94.42 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C94.42?
Clinical documentation must specify the nature of Acute panmyelosis with myelofibrosis, in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference